News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,637 Results
Type
Article (26878)
Company Profile (89)
Press Release (389670)
Section
Business (136589)
Career Advice (1536)
Deals (20430)
Drug Delivery (52)
Drug Development (47156)
Employer Resources (100)
FDA (9848)
Job Trends (9704)
News (218067)
Policy (20027)
Tag
Academia (1774)
Alliances (37302)
Alzheimer's disease (791)
Approvals (9824)
Artificial intelligence (90)
Bankruptcy (170)
Best Places to Work (7711)
Biotechnology (66)
Breast cancer (82)
Cancer (696)
Career advice (1308)
Cell therapy (147)
Clinical research (36909)
Collaboration (289)
Compensation (57)
COVID-19 (1710)
C-suite (53)
Data (737)
Diabetes (111)
Diagnostics (4886)
Earnings (57721)
Employer resources (87)
Events (60364)
Executive appointments (175)
FDA (10164)
Funding (217)
Gene therapy (117)
GLP-1 (381)
Government (2753)
Healthcare (11244)
Infectious disease (1757)
Inflammatory bowel disease (72)
Interviews (268)
IPO (9153)
Job creations (2275)
Job search strategy (1114)
Layoffs (225)
Legal (4939)
Lung cancer (113)
Manufacturing (113)
Medical device (7271)
Medtech (7275)
Mergers & acquisitions (11358)
Metabolic disorders (264)
Neuroscience (957)
NextGen Class of 2024 (3878)
Non-profit (2979)
Northern California (905)
Obesity (140)
Opinion (146)
Patents (65)
People (33617)
Phase I (11299)
Phase II (15785)
Phase III (12944)
Pipeline (354)
Podcasts (56)
Postmarket research (1760)
Preclinical (5169)
Radiopharmaceuticals (152)
Rare diseases (123)
Real estate (3798)
Regulatory (13129)
Research institute (1655)
Resumes & cover letters (232)
Southern California (806)
Startups (2034)
United States (8163)
Vaccines (349)
Weight loss (103)
Date
Today (130)
Last 7 days (697)
Last 30 days (2498)
Last 365 days (22864)
2024 (20659)
2023 (25380)
2022 (32925)
2021 (35138)
2020 (34267)
2019 (28686)
2018 (21379)
2017 (20609)
2016 (20160)
2015 (22945)
2014 (19145)
2013 (16813)
2012 (17064)
2011 (16615)
2010 (15456)
Location
Africa (602)
Arizona (81)
Asia (24202)
Australia (4027)
California (1980)
Canada (809)
China (150)
Colorado (101)
Connecticut (101)
Europe (56065)
Florida (305)
Georgia (75)
Illinois (193)
Indiana (145)
Kansas (61)
Maryland (323)
Massachusetts (1504)
Michigan (88)
Minnesota (137)
New Jersey (646)
New York (622)
North Carolina (495)
Northern California (905)
Ohio (91)
Pennsylvania (472)
South America (836)
Southern California (806)
Texas (278)
Utah (64)
Washington State (221)
416,637 Results for "colossal laboratories and biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.
May 8, 2024
·
9 min read
Lone Star Bio
Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project
Colossal Biosciences, the world’s first de-extinction company, announces that their Woolly Mammoth team has achieved a global-first iPSC breakthrough.
March 6, 2024
·
6 min read
Press Releases
Colossal Achieves Multiple Scientific Firsts in Progress Towards Thylacine De-Extinction
October 17, 2024
·
11 min read
Lone Star Bio
Colossal Announces the Tasmania Thylacine Advisory Committee
Colossal Biosciences, the breakthrough genetic engineering and de-extinction company, is pleased to announce the formation of the Tasmania Thylacine Advisory Committee.
December 20, 2023
·
4 min read
Lone Star Bio
Colossal Announces Expansion of Ancient DNA Academic Research Projects with $7.5M in New Investments, and Issues Call to Researchers
Colossal today announces progress on its ancient DNA agenda and a go-forward vision to enable critical new discoveries from ancient DNA through its academic partners that may prove invaluable to how we navigate our changing climate.
April 15, 2024
·
11 min read
Press Releases
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
November 4, 2024
·
5 min read
Lone Star Bio
Colossal Biosciences Joins BioRescue in Its Mission to Save the Northern White Rhino From Extinction
Colossal Biosciences, the world’s first de-extinction company, and BioRescue, a consortium initiating and leading the scientific rescue mission of the northern white rhino employing advanced assisted reproduction technologies and stem cell associated techniques, have teamed up to save the northern white rhino from extinction.
September 19, 2023
·
9 min read
Lone Star Bio
Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome
Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project, which aims to sequence high-quality reference genomes for all living vertebrates, partnered to successfully generate the first high-quality reference genome of the African elephant.
May 18, 2023
·
6 min read
Biotech Beach
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
Crown Bioscience today announced the dual attainment of College of American Pathologists (CAP) accreditations for its medical laboratory services.
April 11, 2024
·
2 min read
BioForest
Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech
Parse Biosciences today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products.
April 24, 2024
·
2 min read
1 of 41,664
Next
